Loading quotes...

Forecast

The analysts' average price target is €2.63 (+511.63%). The median is €2.63 (+511.63%).

Buy	1
Hold	2
Sell	0

News Go to news feed

TerrAscend reports Q1 growth and higher margins

TerrAscend returned to revenue growth in Q1 2026 with net revenue of $65.5 million and an improved gross margin of 52.8%. Adjusted EBITDA was $17.4 million (26.5% margin), net loss was $6.8 million, and cash rose to $39.1 million. Retail revenue grew sequentially while wholesale revenue declined; the company reported 15 consecutive quarters of positive cash flow. For Q2, TerrAscend expects year-over-year growth of 2–3% and plans a record number of new product SKUs; expected EPS for upcoming quarters is -$0.03. » More on de.investing.com
TerrAscend shareholders approve director elections and option amendments

At the annual meeting, TerrAscend shareholders approved the election of all proposed directors, the reappointment of the auditor, and changes to stock options for insiders. The adjustment of option prices is tied to a minimum service period, which outgoing CFO Keith Stauffer is not expected to fulfill. Despite significant share price losses over the past six months, the company is projected to achieve improved profitability. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2019, Terrascend has already paid €0.55 in dividends. The last payout was in November 2019.

Financials

In the last quarter, Terrascend had revenue of €58.81m and net profit of -€7.06m

(EUR)	June 2026	YoY
Revenue	58.81m	6.63%
Gross profit	31.76m	12.64%
Net profit	-7.06m	83.16%
EBITDA	4.22m	64.52%

Fundamentals

Metric	Value
Market capitalization	€540.28m
Number of shares	349.95m
52-week high/low	€2.77 - €0.90
Dividends	No
Beta	2.00
P/E ratio	-3.69
PEG ratio	-0.03
P/B ratio	1.86
P/S ratio	0.56

Company profile

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania. In addition, it owns various synergistic under Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc. brands. As of April 6, 2022, the company operated 26 dispensaries, including 3 Cookies dispensaries in Michigan and 1 in Toronto. TerrAscend Corp. was incorporated in 2017 and is based in Mississauga, Canada.

Name	Terrascend
CEO	Ziad Ghanem
Headquarters	Mississauga, on Canada
Website	terrascend.com
Sector	Consumer Staples
Industry	Food Products
IPO	17/11/2017
Employees	972